Reports and Presentations

This report provides information regarding $4.1 billion in behavioral health funding reported from SBHCC member agencies and institutions of higher education (including Medicaid behavioral health funding). The proposal links expenditures to strategies in the strategic plan to demonstrate how state appropriations will be used to further plan goals during fiscal year 2022.

This report requires state agencies that pay for the health care of Texans to coordinate data to identify outliers and improvements for efficiency and quality that can be implemented within each health care system.

This quarterly report reflects activities and findings of the Data Analytics Unit.

This fourth quarterly report reflects activities and findings of the Data Analytics Unit for State Fiscal Year 2021.

This third quarterly report reflects activities and findings of the Data Analytics Unit for State Fiscal Year 2021.

This quarterly report reflects activities and findings of the Data Analytics Unit for the first quarter of State Fiscal Year 2021 (SFY21 Q2).

This presentation provides an overview of the rates-setting process, the development of managed care capitation rates, and managed care organization performance and accountability.

This presentation provides an overview of HHS Information Technology, including the agency's 10-Year IT Modernization Plan.

This report discusses the agency’s progress towards meeting targeted Medicaid waiver program slot enrollment and interest list reductions for the 2020-21 biennium, as required in [2020-21 General Appropriations Act, House Bill 1, 86th Legislature, Regular Session, 2019 (Article II, Health and Human Services Commission [HHSC], Rider 20).

The presentation provides an overview of HHSC and the impact of Medicaid and CHIP, as well as an overview of federal funding for these two programs. Additionally, it covers key budget drivers for the agency, Medicaid & CHIP caseload and cost growth, and major category spending. Also addressed is the fiscal impact of COVID-19.